According to the inclusion and exclusion criteria, we totally included 114 patients with COVID-19 (46 death cases and 68 discharged cases) in our study, with two patients with cancers, one with chronic kidney disease, and one without CEA levels excluded. This evidence concerns the gene CEACAM5 and COVID-19.